Hepatitis C virus associated hepatocellular carcinoma

Area of Science:

• Hepatology
• Immunology
• Oncology

Background:

• Hepatocellular carcinoma (HCC) is a prevalent global liver cancer, with chronic hepatitis C virus (HCV) infection being a significant risk factor.
• HCC development involves multistep liver changes, including metabolic disorders, steatosis, and cirrhosis, influenced by environmental and genetic factors.
• Tumor progression in HCC is associated with immune dysfunction, specifically CD8+ T cell exhaustion and accumulation of regulatory T cells (Tregs).

Purpose of the Study:

• To describe the mechanisms of HCV-associated HCC.
• To outline environmental and genetic factors contributing to HCC.
• To highlight current and future therapeutic strategies for HCV and HCC.

Main Methods:

• Review of scientific literature on liver cancer, HCC, and HCV infection.
• Analysis of etiological factors, including viral, metabolic, environmental, and genetic influences.
• Examination of immune regulation and T cell responses in the context of HCC progression.

Main Results:

• Chronic HCV infection is a key driver for approximately 30% of HCC cases.
• HCC pathogenesis involves initiation of neoplastic clones and progression influenced by immune exhaustion.
• Accumulation of PD-1hi CD8+ T cells and Tregs is observed during tumor progression.

Conclusions:

• HCV infection significantly contributes to HCC development through complex biological pathways.
• Understanding immune dysregulation is crucial for managing HCC progression.
• Novel therapeutic opportunities are emerging for both HCV treatment and HCC management.